ArticleUnited European gastroenterology journal2019

Recurrence rate of hepatocellular carcinoma in patients with treated hepatocellular carcinoma and hepatitis C virus-associated cirrhosis after ombitasvir/paritaprevir/ritonavir+dasabuvir+ribavirin therapy.

Carmen M Preda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.